Hint: Code G9531 will see some revisions in 2020. The Centers for Medicare & Medicaid Services (CMS) recently published the 2020 HCPCS Level II code changes. These updates will become effective on Jan. 1, 2020. Read on to learn more about how the new revisions, additions, deletions, and the new modifiers will impact your neurosurgery practice during the coming year. Focus On These Shiny New Codes Take a look at the following new 2020 HCPCS Level II codes you can expect to see in 2020 for neurosurgery: “Keep in mind that the creation of a level II HCPCS code does not inform you regarding whether a commercial carrier will cover the specified service,” says Gregory Przybylski, MD, immediate past chairman of neuroscience and director of neurosurgery at the New Jersey Neuroscience Institute, JFK Medical Center in Edison, New Jersey. “For example, C9757 describes a combination of the service included in 63030 for unilateral lumbar discectomy but adds the service of annular repair with a closure device. The latter service may be considered experimental, investigational and/or unproven and therefore not a covered service.” Don’t miss: If you look through the HCPCS Level II code set for 2020, you will see 41 new codes with duplicate descriptors and 12 revised codes with duplicate descriptors. The new codes for a degenerative neurological condition that the neurosurgeon diagnoses any time before or during the episode of care fall in this category. Currently, HCPCS Level II lists the following seven new codes with the exact same code descriptor. Hopefully this mistake will be clarified soon, but for now, here are the codes as they currently appear in the HCPCS Level II new codes list: Dial Into 3 Important Revisions Make sure you know which HCPCS Level II revisions to look for in 2020. Revision 1: For example, G9531 (Patient has documentation of ventricular shunt, brain tumor, multisystem trauma, pregnancy, or is currently taking an antiplatelet medication including: abciximab, anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide, prasugrel, ticlopidine, ticagrelor, tirofiban, or vorapaxar) will see a couple of revisions. Emphasis added. As you can see, pregnancy is no longer included under the documented conditions in the code descriptor. Also, this revision will add “anagrelide” and “dipyridamole” to the code descriptor, which describe antiplatelet medications a patient might be currently taking. Revision 2: Documentation code G9595 (Patient has documentation of ventricular shunt, brain tumor, or coagulopathy, including thrombocytopenia) will also see a minor revision. Emphasis added. As you can see, the revised descriptor for G9595 will delete the words “including thrombocytopenia.” Revision 3: Code G8674 (Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the general orthopedic fs prom at initial evaluation fs status survey on admission and/or follow up fs status survey and/or near discharge, reason not given) will also see some revisions. As you can see, the type of fs was changed to “general orthopedic fs prom,” and the descriptor now clarifies that it will be given at the patient’s initial evaluation. Don’t Miss 2 Deletions You will also lose two HCPCS Level II codes in 2020. They are as follows: Observe New Modifier Options and 1 Deletion You’ll see eight new HCPCS Level II modifiers in 2020. They are as follows: Deletion: You will lose modifier GD (Units of service exceeds medically unlikely edit value and represents reasonable and necessary services) in 2020.